Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a

J Neuroimaging. 2013 Jul;23(3):337-44. doi: 10.1111/j.1552-6569.2011.00682.x. Epub 2011 Dec 30.

Abstract

Background and purpose: Botulinum toxin (BoNT) treatment relieves focal arm spasticity after stroke, likely acting at several hierarchical levels of the motor system. The central correlate of BoNT-induced spasticity relief may be detected using repeated functional MRI (fMRI) during motor task.

Methods: Five patients (4 males, 1 female, mean age 67 years) with hemiparesis and distal arm spasticity after chronic ischemic stroke were studied. FMRI was performed while moving the paretic hand in three sessions: before and 4 and 11 weeks after BoNT treatment.

Results: Arm spasticity significantly decreased following BoNT treatment across the group (mean modified Ashworth scale change .6). FMRI prior to BoNT treatment showed extensive bilateral active networks, whereas post-BoNT activation was limited to midline and contralateral sensorimotor cortices, and the third examination, when the toxin effect has worn off, again showed extensive activation similar to pre-BoNT examination. Post-BoNT session 2 compared to sessions 1 and 3 demonstrated a significantly less activation in contralateral frontoparietal areas including inferior frontal, postcentral, and middle frontal gyri as well as transient crossed cerebellar activation.

Conclusion: Relief of post-stroke arm spasticity may be associated with changes at several hierarchical levels of the cortical sensorimotor system, including the prefrontal cortex.

Keywords: Stroke; arm spasticity; botulinum toxin; finger movement; functional magnetic resonance imaging.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arm
  • Botulinum Toxins, Type A / therapeutic use*
  • Evoked Potentials*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Movement
  • Muscle Spasticity / drug therapy*
  • Muscle Spasticity / etiology
  • Muscle Spasticity / physiopathology*
  • Neuromuscular Agents / therapeutic use
  • Sensorimotor Cortex / drug effects
  • Sensorimotor Cortex / physiopathology*
  • Stroke / complications
  • Stroke / drug therapy*
  • Stroke / physiopathology*
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A